We found that NSCLC with high SIRPG expression was significantly correlated with high expression levels of antigen presentation machinery, immunostimulatory, immunoinhibitory molecules, as well as high expression of genes regulating T cell activation and cytotoxicity, suggesting that lung tumors with high SIRPG expression had inflamed immune phenotypes. This evidence concerns the gene SIRPG and non-small cell lung carcinoma.